Baillie Gifford co-leads $110m financing deal for gene therapy developer Orchard Therapeutics Edinburgh-based fund manager Baillie Gifford is continuing its foray into biotech investing, by co-leading a large $110m (£85m) Series B venture deal for Orchard Therapeutics, a Anglo-US company working on gene therapies for rare disorders. The specific Baillie Gifford-managed funds that have provided the […]
Prothena drag on Woodford Patient Capital A 45% fall in the value of its large shareholding in Prothena since the end of the third quarter seems to have been the main factor behind a decline in the value of Woodford Patient Capital Trust (WPCT) over the same period, according to the trust’s latest monthly update. WPCT’s shares have […]
Post IPO fall for Nightstar hits Syncona A fall in the post IPO share price of Nasdaq-listed, UK-based gene therapy specialist Nightstar Therapeutics marred an otherwise strong performance for UK biotech investment trust Syncona (SYNC) in November, whose NAV dipped by 4% in the month, according to its latest monthly update. Syncona’s 42% ownership of Nightstar […]
LXB Retail Properties sells its investments in Stafford – LXB Retail Properties has exchanged contracts for the disposal of its two remaining investments at Stafford. It is also updating on further lettings at Rushden Lakes and Sutton. On 21 December 2017, the Group exchanged contracts for the sale of its retail investment at Riverside, Stafford to […]
Phoenix Spree Deutschland sells 34 properties – Phoenix Spree Deutschland has exchanged contracts to sell a portfolio of 34 properties located in Central and Northern Germany for an aggregate cash consideration of EUR73.0m. On completion of the disposal, and including further acquisitions and disposals notarised since 30 June 2017, Berlin is expected to represent over 99% […]
BlackRock Income and Growth says stock selection aided performance – BlackRock Income and Growth Investment Trust has published its annual report for the year ended 31 October 2017. During the year the NAV returned 13.8% and the share price returned 14.8%. By comparison, the benchmark, the All-Share Index, returned 13.4%. The board has declared total dividends for the year of […]
Ecofin Global Utilities and Infrastructure off to a good start – Ecofin Global Utilities and Infrastructure Trust has published annual results. The company’s shares were first listed on the London Stock Exchange on 26 September, 2016 and these results are for the financial year which ended on 30 September, 2017. In that period, the net asset […]
Polar Capital Global Healthcare reflects on year of transition – Polar Capital Global Healthcare, announcing its results for the year ended 30 September 2017, says that its NAV total return for the year amounted to 0.6% compared to a rise in the benchmark (the MSCI Global Healthcare Index) of 8.6%. Meanwhile their share price total […]
VinaLand sells Trinity Garden – VinaLand Limited has divested its entire stake in the Trinity Garden project. The project, located in Ho Chi Minh City, Vietnam and acquired by VinaLand in 2007, is a 13.7-hectare parcel of land designated for a future development. VinaLand will divest its entire stake in the project to Ms. Tran […]
DRUM Income Plus REIT targets 6.3% yield for 2018 – Drum Income Plus REIT says that, for the 12 month period to 30 September 2017, its NAV increased by 0.5% to 94p. When the dividends paid during the period are taken into account the NAV total return for the twelve months to 30 September 2017 […]
